Related Experiment Video
Updated: Jul 16, 2026
06:16
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
Electrically assisted ocular gene therapy
Riad Antoine Bejjani1, Charlotte Andrieu, Carole Bloquel
1Unit INSERM U598, René Descartes Paris 5 University, Paris, France.
Survey of Ophthalmology
|March 16, 2007
Summary
Electrotransfer and iontophoresis are innovative gene delivery methods for eye diseases, using electric currents for efficient transfection of ocular cells. These safe, non-viral techniques are nearing clinical application for treating various eye conditions.
Area of Science:
- Ophthalmology
- Biotechnology
- Gene Therapy
Background:
- Non-viral gene delivery systems are crucial for treating eye diseases.
- Electrotransfer and iontophoresis utilize electric current for enhanced gene delivery to ocular tissues.
- These methods offer alternatives to viral vectors for in vivo transfection.
Purpose of the Study:
- To review the principles and therapeutic potential of electrotransfer and iontophoresis for ocular diseases.
- To assess the efficiency and safety of these non-viral gene delivery systems.
- To highlight their progress towards clinical implementation.
Main Methods:
- Electrotransfer uses short, high-intensity electric pulses for gene delivery.
- Iontophoresis employs low-voltage electric current for transfection.
- Both techniques are applied in vivo to various ocular cell types.
Main Results:
- Iontophoresis is effective for delivering small nucleic acids like siRNA and antisense oligonucleotides.
- Electrotransfer is suitable for delivering oligonucleotides and plasmids.
- Both methods demonstrate efficient and targeted gene delivery to ocular tissues with a good safety profile.
Conclusions:
- Electrotransfer and iontophoresis are promising non-viral gene delivery systems for treating anterior and posterior segment eye diseases.
- These techniques are safe, efficient, and nearing clinical application for ocular gene therapy.
- Further development and validation pave the way for bedside implementation.
More Related Videos
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...